{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:53:00Z","timestamp":1782906780701,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canrad.2026.104831","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:06:30Z","timestamp":1780607190000},"page":"104831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series"],"prefix":"10.1016","volume":"30","author":[{"given":"Pierre","family":"Loap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bouscary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2026.104831_bib0230","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.21037\/tcr-22-671","article-title":"Misdiagnosis of primary mucosa-associated lymphoid tissue lymphoma of the pleura: case report and literature review","volume":"11","author":"Wang","year":"2022","journal-title":"Transl Cancer Res"},{"issue":"5","key":"10.1016\/j.canrad.2026.104831_bib0235","first-page":"487","article-title":"A case of follicular lymphoma from the chest wall","volume":"71","author":"Mamoto","year":"2012","journal-title":"Jpn J Chest Dis"},{"key":"10.1016\/j.canrad.2026.104831_bib0240","first-page":"251","article-title":"Rare case of primary extranodal marginal zone lymphoma of the thorax","volume":"26","author":"Ben Saad","year":"2019","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.canrad.2026.104831_bib0245","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.21037\/apm-20-1480","article-title":"A rare case of indolent B cell lymphoma with massive pleural effusion as the initial presentation","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.canrad.2026.104831_bib0250","first-page":"e73462","article-title":"Pleural marginal zone lymphoma masquerading as metastatic adenocarcinoma of the lung","volume":"16","author":"Onatsko","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.canrad.2026.104831_bib0255","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00066-025-02404-0","article-title":"Radiotherapy of localized orbital mantle cell lymphoma: a SEER database analysis of long-term outcomes","volume":"201","author":"Loap","year":"2025","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2026.104831_bib0260","doi-asserted-by":"crossref","first-page":"104629","DOI":"10.1016\/j.canrad.2025.104629","article-title":"Comprehensive analysis of uveal mucosa-associated lymphoid tissue lymphomas: Epidemiological insights and radiotherapy utilization from the Surveillance, Epidemiology and End Results database","volume":"29","author":"Loap","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104831_bib0265","doi-asserted-by":"crossref","first-page":"104588","DOI":"10.1016\/j.canrad.2025.104588","article-title":"Long-term cardiac mortality in patients treated with radiation for gastric mucosa-associated lymphoid tissue lymphoma","volume":"29","author":"Loap","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104831_bib0270","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S2352-3026(24)00133-9","article-title":"Response-adapted ultra-low-dose 4Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial","volume":"11","author":"Gunther","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.canrad.2026.104831_bib0275","doi-asserted-by":"crossref","first-page":"681689","DOI":"10.3389\/fonc.2021.681689","article-title":"Long-term clinical outcomes of gastric MALT lymphoma: a nationwide multicenter study in Korea","volume":"11","author":"Kim","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2026.104831_bib0280","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ijrobp.2024.10.020","article-title":"Reduced-dose radiation therapy for stage IE gastric mucosa-associated lymphoid tissue lymphoma: a multi-institutional prospective study (KROG 16-18)","volume":"121","author":"Jeon","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104831_bib0285","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1182\/blood-2024-198992","article-title":"Treatment and outcomes of stage I\u2013II pulmonary MALT lymphoma: a multi-institutional observational study in Japan","volume":"144","author":"Suzuki","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2026.104831_bib0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104831_bib0295","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","article-title":"Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program","volume":"8","author":"Gloeckler Ries","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2026.104831_bib0300","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2169\/internalmedicine.56.7053","article-title":"Primary malignant lymphoma originating from the chest wall without preceding pleural disease","volume":"56","author":"Iwasa","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.canrad.2026.104831_bib0305","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1440-1827.2008.02220.x","article-title":"Pleural MALT lymphoma diagnosed on thoracoscopic resection under local anesthesia using an insulation-tipped diathermic knife","volume":"58","author":"Kawahara","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.canrad.2026.104831_bib0310","first-page":"165","article-title":"[Marginal zone lymphoma of mucosa-associated lymphoid tissue of the parietal pleura; report of a case]","volume":"67","author":"Inoue","year":"2014","journal-title":"Kyobu Geka"},{"key":"10.1016\/j.canrad.2026.104831_bib0315","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/bloodadvances.2021004939","article-title":"Excellent response to very-low-dose radiation (4Gy) for indolent B-cell lymphomas: is 4Gy suitable for curable patients?","volume":"5","author":"Imber","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.canrad.2026.104831_bib0320","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood.2020006028","article-title":"ILROG emergency guidelines for radiation therapy of hematological malignancies during the Covid-19 pandemic","volume":"135","author":"Yahalom","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2026.104831_bib0325","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jha2.335","article-title":"Role of bridging therapy during chimeric antigen receptor T cell therapy","volume":"3","author":"Bhaskar","year":"2021","journal-title":"EJHaem"},{"key":"10.1016\/j.canrad.2026.104831_bib0330","doi-asserted-by":"crossref","first-page":"104595","DOI":"10.1016\/j.canrad.2025.104595","article-title":"Exposure to the immune system during bridging radiotherapy for CAR-T cells","volume":"29","author":"Loap","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104831_bib0335","doi-asserted-by":"crossref","first-page":"109933","DOI":"10.1016\/j.radonc.2023.109933","article-title":"Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy","volume":"189","author":"Ababneh","year":"2023","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104831_bib0340","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjh.19453","article-title":"Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK","volume":"205","author":"Kuhnl","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.canrad.2026.104831_bib0345","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fonc.2018.00087","article-title":"Deep inspiration breath hold: techniques and advantages for cardiac sparing during breast cancer irradiation","volume":"8","author":"Bergom","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2026.104831_bib0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2022.10.003","article-title":"Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations","volume":"177","author":"Patel","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2026.104831_bib0355","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2026.104831_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aol-20-28","article-title":"Epidemiology of marginal zone lymphoma","volume":"5","author":"Cerhan","year":"2021","journal-title":"Ann Lymphoma"},{"key":"10.1016\/j.canrad.2026.104831_bib0365","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1183\/13993003.01701-2015","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma revisited","volume":"47","author":"Borie","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.canrad.2026.104831_bib0370","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jso.21976","article-title":"Does surgery or radiation therapy impact survival for patients with extrapulmonary small cell cancers?","volume":"104","author":"Grossman","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.canrad.2026.104831_bib0375","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2015-11-632745","article-title":"Is watch and wait still acceptable for patients with low-grade follicular lymphoma?","volume":"127","author":"Armitage","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2026.104831_bib0380","doi-asserted-by":"crossref","first-page":"779395","DOI":"10.3389\/fonc.2022.779395","article-title":"Clinical features and surgical treatment of primary pulmonary lymphoma: a retrospective study","volume":"12","author":"Shen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2026.104831_bib0385","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/S2352-3026(21)00167-8","article-title":"Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions","volume":"8","author":"Bennett","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.canrad.2026.104831_bib0390","series-title":"Annual update in intensive care and emergency medicine 2018","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-73670-9_43","article-title":"Rituximab-related severe toxicity","author":"Ghrenassia","year":"2018"},{"key":"10.1016\/j.canrad.2026.104831_bib0395","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/0284186X.2023.2177976","article-title":"Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT)","volume":"62","author":"Loap","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2026.104831_bib0400","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canrad.2020.05.016","article-title":"Evaluating cardiac substructure radiation exposure in breast rotational intensity modulated radiation therapy: effects of cancer laterality, fractionation and deep inspiration breath-hold","volume":"25","author":"Loap","year":"2021","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.canrad.2026.104831_bib0405","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2019.12.006","article-title":"The limits of the linear quadratic (LQ) model for late cardiotoxicity prediction: example of hypofractionated rotational intensity modulated radiation therapy (IMRT) for breast cancer","volume":"106","author":"Loap","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2026.104831_bib0410","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.prro.2022.02.004","article-title":"Development of simplified autosegmentable functional cardiac atlas","volume":"12","author":"Loap","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2026.104831_bib0415","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.prro.2021.02.002","article-title":"A radiotherapy contouring atlas for cardiac conduction node delineation","volume":"11","author":"Loap","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104831_bib0420","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.canrad.2020.04.012","article-title":"Evaluation of a delineation software for cardiac atlas-based autosegmentation: an example of the use of artificial intelligence in modern radiotherapy","volume":"24","author":"Loap","year":"2020","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104831_bib0425","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/0284186X.2022.2084639","article-title":"Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy","volume":"61","author":"Loap","year":"2022","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2026.104831_bib0430","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.canrad.2021.06.016","article-title":"Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience","volume":"25","author":"Loap","year":"2021","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104831_bib0435","doi-asserted-by":"crossref","first-page":"100110","DOI":"10.1016\/j.ijpt.2024.100110","article-title":"Proton therapy reduces the effective dose to immune cells in mediastinal Hodgkin lymphoma patients","volume":"13","author":"Loap","year":"2024","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.canrad.2026.104831_bib0440","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/cancers13153744","article-title":"Development and implementation of proton therapy for Hodgkin lymphoma: challenges and perspectives","volume":"13","author":"Loap","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2026.104831_bib0445","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.3390\/cancers13153746","article-title":"Current situation of proton therapy for Hodgkin lymphoma: from expectations to evidence","volume":"13","author":"Loap","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2026.104831_bib0450","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/0284186X.2021.2025265","article-title":"Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation","volume":"61","author":"Loap","year":"2022","journal-title":"Acta Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182600034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182600034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:37:41Z","timestamp":1782905861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832182600034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S127832182600034X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104831","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104831"}}